News from bayer healthcare A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 22, 2013, 17:30 ET
Nov 20, 2013, 11:14 ET

Bayer's Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community

 Bayer HealthCare and the National Hemophilia Foundation (NHF) today announced the successful conclusion of the third annual...

Nov 20, 2013, 09:00 ET

Bayer HealthCare Awards Veterinary Students $72,500 in Scholarship Funds for Communications Excellence

 Bayer HealthCare LLC, Animal Health division announces the launch of the 2014 Bayer Excellence in Communication Award. Rolled...

Nov 15, 2013, 05:16 ET

Bayer Receives Approval for Xofigo® (radium Ra 223 dichloride) Injection in Europe

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo® (radium Ra 223...

Oct 29, 2013, 09:12 ET

500,000 People Call for Urgent Action to Prevent Atrial Fibrillation-Related Strokes

-Not intended for U.K. media- Atrial fibrillation is an under-diagnosed, undertreated abnormal heart rhythm that increases stroke risk five-fold...

Oct 28, 2013, 20:01 ET

500,000 People Call for Urgent Action to Prevent Atrial Fibrillation-Related Strokes

Atrial fibrillation is an under-diagnosed, undertreated abnormal heart rhythm that increases stroke risk five-fold compared to the general...

Oct 28, 2013, 09:51 ET

Bayer to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets

 Bayer HealthCare today announced preliminary results from two ongoing, open-label, long-term extension studies investigating its recently...

Oct 21, 2013, 10:00 ET

Bayer's CONTOUR® NEXT LINK Cleared For Use With Medtronic's New MiniMed® 530G With Enlite®

Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR® NEXT LINK blood glucose monitoring...

Oct 16, 2013, 12:39 ET
The honorable Chris Christie, Governor, State of New Jersey joins President of Bayer HealthCare Phil Blake, and  Marijn Dekkers, Chairman, Bayer AG Group, Board of Management at the ribbon cutting ceremony for the grand opening of the new Bayer HealthCare U.S. headquarters in Whippany, N.J.   (PRNewsFoto/Bayer HealthCare)

Bayer HealthCare Celebrates Opening of State-of-the Art U.S. Headquarters in Whippany

 Bayer HealthCare today announced the opening of its new U.S. headquarters on a 94-acre campus in Whippany, New Jersey, within...

Oct 09, 2013, 08:00 ET

MULTIMEDIA ASSETS NOW AVAILABLE: FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...

Oct 08, 2013, 18:54 ET

FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...

Oct 03, 2013, 08:32 ET

Bayer Introduces Kogenate® FS Antihemophilic Factor (Recombinant) with Vial Adapter at 2013 NHF Meeting

 Bayer HealthCare announced today that the company is introducing Kogenate® FS antihemophilic factor (recombinant) with Vial Adapter. Vial...

Oct 01, 2013, 09:00 ET

Bayer HealthCare Wants You To Vote For Your Favorite "Chatty Cat"!

 The official voting period for Bayer HealthCare Animal Health's Advantage® II for cats Chatty Cat Challenge opens today....

Sep 25, 2013, 08:30 ET

Bayer's Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

WHIPPANY, N.J., Sept. 25, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA)...

Sep 24, 2013, 10:58 ET

Rosacea Concierge Sets the Bar for Patient Support with Unique Resources

Rosacea Concierge, a one-of-a-kind resource for the estimated 16 million people living with rosacea1, has been launched by Bayer HealthCare. The...

Sep 20, 2013, 09:20 ET

Zusammengefasste Ergebnisse der EINSTEIN-Phase-III-Studien bestätigen Xarelto® von Bayer als effektives Monotherapeutikum bei venösen Thromboembolien

Behandlung und Prävention venöser Blutgerinnsel: - Alle 37 Sekunden stirbt ein Mensch in der westlichen Welt an Blutgerinnseln,...

Sep 20, 2013, 07:40 ET

Xofigo® (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union

 Bayer HealthCare announced today that the the European Committee for Medicinal Products for Human Use (CHMP) recommended Xofigo® (radium...

Sep 17, 2013, 08:30 ET

Bayer to Present Data on Multiple Oncology Compounds at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013

 Bayer HealthCare announced  today that data from the company's oncology portfolio, including Nexavar® (sorafenib)...

Sep 12, 2013, 14:22 ET
Sheryl Crow, One A Day Women's Nutrition Mission grant competition winner in NYC.  (PRNewsFoto/Bayer HealthCare LLC)

One A Day® Women's, Feeding America® and Sheryl Crow Celebrate Heroes on a "Nutrition Mission" to Fight Hunger in Local Communities

Food insecurity is a problem in America, with some low-income families having to choose, at times, between buying food essentials and paying the...

Sep 10, 2013, 08:01 ET

Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy

 Bayer HealthCare has entered into a strategic alliance with the Broad Institute in Cambridge, Massachusetts in the area of oncogenomics and...